Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 2,925,098 | reported | 11 Mar 2025 | tx 61+4,660,841−337,158 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | GRANT_AWARD | Cardiff Oncology, Inc. | 758,400 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Cardiff Oncology, Inc. | 510,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | Cardiff Oncology, Inc. | 482,064 | 0.00 USD | deriv |
| 25 Nov 2022 | PURCHASE | Cardiff Oncology, Inc. | 10,000 | 1.43 USD | first after silence |
| 09 Mar 2022 | GRANT_AWARD | Cardiff Oncology, Inc. | 370,128 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Cardiff Oncology, Inc. | 435,072 | 0.00 USD | deriv |
| 23 Mar 2021 | PURCHASE | Cardiff Oncology, Inc. | 965 | 10.34 USD | |
| 02 Jan 2021 | EXERCISE | Cardiff Oncology, Inc. | 260 | 0.00 USD | |
| 02 Jan 2021 | TAX_WITHHOLDING | Cardiff Oncology, Inc. | 113 | 0.00 USD | |
| 02 Jan 2021 | EXERCISE | Cardiff Oncology, Inc. | 260 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | Cardiff Oncology, Inc. | 221,241 | 0.00 USD | deriv |
| 14 May 2020 | PURCHASE | Cardiff Oncology, Inc. | 6,993 | 1.43 USD | first after silence |
| 02 Jan 2020 | EXERCISE | Cardiff Oncology, Inc. | 261 | 0.00 USD | |
| 03 Jan 2020 | TAX_WITHHOLDING | Cardiff Oncology, Inc. | 116 | 0.00 USD | |
| 02 Jan 2020 | EXERCISE | Cardiff Oncology, Inc. | 261 | 0.00 USD | deriv |
| 01 Jan 2020 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | |
| 03 Jan 2020 | TAX_WITHHOLDING | Cardiff Oncology, Inc. | 552 | 0.00 USD | |
| 01 Jan 2020 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | deriv |
| 01 Oct 2019 | TAX_WITHHOLDING | Cardiff Oncology, Inc. | 466 | 0.00 USD | |
| 01 Oct 2019 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | |
| 01 Oct 2019 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | deriv |
| 01 Jul 2019 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | |
| 01 Jul 2019 | TAX_WITHHOLDING | Cardiff Oncology, Inc. | 461 | 0.00 USD | |
| 01 Jul 2019 | EXERCISE | Cardiff Oncology, Inc. | 1,250 | 0.00 USD | deriv |
| 20 Jun 2019 | GRANT_AWARD | Cardiff Oncology, Inc. | 134,203 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 25 Nov 2022.